Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method for preparing gram-negative pathogenic bacteria inactivated vaccine having cross-protection power

A Gram-negative, inactivated vaccine technology, which is applied in the field of preparation of Gram-negative pathogenic bacteria inactivated vaccines, can solve the problems of high vaccine cost, inability to be widely used, and complicated outer membrane protein extraction process

Inactive Publication Date: 2009-12-02
徐海军
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The vaccine prepared by this process has a good cross-immune protection effect, but the extraction process of the outer membrane protein is complicated and requires the use of ultra-fast refrigerated centrifugation, which makes the cost of the prepared outer membrane protein vaccine too high and cannot be widely used in production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for preparing gram-negative pathogenic bacteria inactivated vaccine having cross-protection power
  • Method for preparing gram-negative pathogenic bacteria inactivated vaccine having cross-protection power
  • Method for preparing gram-negative pathogenic bacteria inactivated vaccine having cross-protection power

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0004] Embodiment 1: The present invention is used in the preparation method of fowl cholera propolis inactivated vaccine and its immunoprotective experiment. The virulent freeze-dried strain of Pasteurella multocida type A involved in this example was purchased from the China Veterinary Drug Control Institute, and was identified and preserved by the institute. 1. Preparation of bacteria solution for strain rejuvenation and seedling preparation:

[0005] After the freeze-dried bacteria were dissolved in 1ml of sterile physiological saline, they were streaked and inoculated on the blood Martin agar medium, and cultured at 37°C for 20-22 hours. The grown bacteria were washed and rejuvenated by continuous passage twice in the chicken body. The liver disease material was taken and inoculated on the blood Martin agar plate by streaking, and cultured at 37°C for 20-22 hours. 4-6 typical colonies were streaked and inoculated on blood Martin agar slant, and cultured at 37°C for 20-22...

Embodiment 2

[0023] Embodiment two: the present invention is used for the preparation method of Escherichia coli inactivated vaccine and its immunoprotective experiment

[0024] The standard Escherichia coli CMCC44115 strain freeze-dried bacterial classification that this embodiment relates to (serotype is O 2 type), purchased from the China Veterinary Drug Control Institute, identified and preserved by the institute.

[0025] 1. Rejuvenation of strains and preparation of bacterial solution for seedling production

[0026]After the freeze-dried bacteria were dissolved in 1ml of sterile physiological saline, they were streaked and inoculated on the blood Martin agar medium, and cultured at 37°C for 20-22 hours. The grown bacteria were washed and rejuvenated by continuous passage twice in the chicken body. The liver disease material was taken and inoculated on the blood martin agar culture plate by streaking, and cultured at 37°C for 20-22 hours. 4-6 typical colonies were streaked and inoc...

Embodiment 3

[0037] Embodiment 3: The present invention is used in the preparation method of the R. anatipestifer vaccine and its immune protection experiment.

[0038] The freeze-dried strain of R. anatipestifer (serotype I) involved in this example was isolated from clinically dead ducks.

[0039] 1. Rejuvenation of strains and preparation of bacterial solution for seedling production

[0040] Freeze-dried strains were dissolved in 1ml sterile saline, inoculated in serum nutrient broth, and cultured at 37°C for 16-18 hours. Take the culture solution and inoculate it on a serum nutrient agar plate, and incubate at 37°C for 16-18 hours. The grown bacteria were washed with sterilized saline and used as seed solution. The seed liquid is inoculated into the broth culture medium containing heme serum used for making the vaccine according to the ratio of 5% of the culture fluid volume, and 200 μmol / L 2,2'bipyridyl has been added in the broth culture medium as an iron chelating agent. It can ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
molecular weightaaaaaaaaaa
Login to View More

Abstract

The invention discloses a preparation method of an inactivated vaccine of Gram-negative pathogenic bacteria with cross-protection, which comprises the following steps: a. adopting a solid culture medium or a liquid culture medium added with an iron chelating agent, taking strains for rejuvenation and using The medium is cultured in vitro; b. Wash the bacteria cultured on the solid medium with sterilized vaccine diluent until the final bacterial concentration reaches the industry standard; or the above-mentioned final bacterial concentration is lower than the industry standard Concentrate the bacterium solution and the bacterium solution cultivated with liquid medium, retain the thalline and the shedding outer membrane protein, until the final concentration of the bacterium solution reaches the industry standard; c, the volume percentage of the final bacterium solution obtained in step b is 0.1 -0.3% formaldehyde is inactivated; d, adding an adjuvant to make a vaccine. The method of the invention has simple process, low manufacturing cost and easy industrialization.

Description

technical field [0001] The invention relates to a preparation method of an inactivated vaccine of Gram-negative pathogenic bacteria. Background technique [0002] Many Gram-negative bacteria are important pathogens, such as certain serotypes of Escherichia coli, Salmonella, Pasteurella multocida, and R. anatipestifer. These pathogenic bacteria lead to high morbidity and mortality in poultry, and have brought great harm to the poultry farming industry and human health. Due to the complex antigenic composition and numerous serotypes of Gram-negative bacteria, inactivated vaccines prepared by in vitro culture can only protect against infection by homotype bacteria, but basically have no protective effect on infection by heterotype bacteria. This feature of Gram-negative bacteria has brought great difficulties to the immune prevention of corresponding poultry infectious diseases. Studies have shown that Gram-negative bacteria can express cross-protective factor (CPF) when grow...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K39/02A61K39/106A61K39/108A61K39/39A61P31/04
Inventor 徐海军
Owner 徐海军
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products